Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lung Cancer
100%
Patient Survival
100%
Tumor Growth
100%
EEF2
100%
Elongation Factor 2 Kinase
100%
Small Interfering RNA (siRNA)
42%
Lung Cancer Cells
42%
Cyclin D1 (CCND1)
28%
Mitogen-activated Protein Kinase/extracellular Signal-regulated Kinase
28%
Colony Formation
28%
Quantitative PCR
14%
Recent Advances
14%
Western Blotting
14%
Treatment Options
14%
Tumor Progression
14%
Cancer Tumor
14%
Kinase Family
14%
Patient Prognosis
14%
Survival Migration
14%
Tumor Xenograft
14%
Highly Effective
14%
Tumorigenesis
14%
Cancer Causes
14%
Cancer Mortality
14%
Lung Cancer Cell Lines
14%
Molecular Targets
14%
Xenograft Mice
14%
Liposomal
14%
Athymic
14%
Proliferation Ability
14%
Molecular Targeted Therapy
14%
Novel Therapeutic Targets
14%
Tumor Xenograft Model
14%
Gene Knockout
14%
Putative Drug Targets
14%
Matrigel Invasion Assay
14%
Targeted Therapeutics
14%
Extracellular Signal-regulated Kinase Signaling
14%
Migration Invasion
14%
SiRNA Transfection
14%
Cancer Cell Proliferation
14%
In Vivo Targeting
14%
Lung Cancer Biology
14%
α-kinase
14%
Metastatic Ability
14%
Nanoliposomal
14%
Medicine and Dentistry
Lung Cancer
100%
Tumor Progression
100%
Elongation Factor 2 Kinase
100%
extracellular signal regulated kinase
40%
Small Interfering RNA
40%
Cancer Cell
30%
Tumor Xenograft
20%
Colony Formation
20%
Cyclin D1
20%
Malignant Neoplasm
10%
Cell Proliferation
10%
Carcinogenesis
10%
Western Blot
10%
Kinase Signaling
10%
Genetic Transfection
10%
Lung Cancer Cell Line
10%
Cyclic AMP Dependent Protein Kinase
10%
Reverse Transcription Polymerase Chain Reaction
10%
Matrigel
10%
Molecularly Targeted Therapy
10%
Kinase
10%
Gene Knockdown
10%
Clinical Pathway
10%
Treatment Option
10%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Elongation Factor 2 Kinase
100%
Eukaryotic Elongation Factors
100%
Cancer Cell
50%
Small Interfering RNA
50%
extracellular signal regulated kinase
25%
Cyclin D1
25%
Extracellular Signal-Regulated Kinases
25%
Colony Formation
25%
Cell Proliferation
12%
Western Blot
12%
Transfection
12%
Nude Mouse
12%
Carcinogenesis
12%
Reverse Transcription Polymerase Chain Reaction
12%
Protein Kinase A
12%
Gene Knockdown
12%
Targeted Therapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Tumor Growth
100%
Elongation Factor 2 Kinase
100%
Mitogen Activated Protein Kinase
36%
Small Interfering RNA
36%
Neoplasm
18%
Cyclin D1
18%
Malignant Neoplasm
9%
Nude Mouse
9%
Western Blot
9%
Carcinogenesis
9%
Cyclic AMP Dependent Protein Kinase
9%
Molecular Target
9%
Matrigel
9%